Nov 14 (Reuters)-
Phoenixbio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2018 Sep 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 426 mln 316 mln 1.28
(+34.9 pct) (-43.3 pct) (+41.5 pct)
Operating loss 265 mln loss 226 mln loss 124 mln
Recurring loss 249 mln loss 220 mln loss 113 mln
Net loss 251 mln loss 221 mln loss 129 mln
EPS loss 86.18 yen loss 76.49 yen loss 44.45 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T